Mpact 3D Metal Monolit Study
ConditionTotal Hip Arthroplasty (THA)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorMedacta International SA
About this trial
Total hip arthroplasty (THA) is one of the most common operations performed in orthopaedics to improve a patient's quality of life.
Surgeons are constantly seeking to improve all aspects of care related to this procedure, whether it be improving implant technology, improving instrumentation or the technique involved in performing the procedure.
In recent years, a new porous titanium coating has been introduced to promote good osseointegration of uncemented cups. High friction torque and a feeling of immediate anchorage provide excellent primary stability, while high porosity ensures bone growth providing secondary stability. With higher porosity than standard coatings, a greater volume of bone can be present in the porous surface, giving a proportional increase in force at the interface. he Mpact 3D Metal Monolith cup has been designed to provide greater range of motion and improved joint stability, with a reduced risk of dislocation. It is an innovative design that improves stability and provides a favourable environment for long-term biological metal-bone fixation.
The current study aims to collect clinical and radiological data to assess the function of the operated hip and the stability of the Mpact 3D Metal Monolith cup at 2 years and survival at 5 years for the treatment of patients requiring hip arthroplasty.
Eligibility criteria
Qualifiers
Patient with a disease that corresponds to the indications for use of Medacta implants (according to the instructions for use)
Patient eligible for primary total hip arthroplasty
Patient aged between 18 and 75 years
Patient covered by the French Social Security system or an equivalent protection scheme.
Disqualifiers
Patient suffering from inflammatory arthritis
Previously operated hip
Patient requiring a transplant
Hip tumour involved
Trial design
Treatments tested in this trial
- Mpact 3D Metal Monolith
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov